ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 137 filers reported holding ARRAY BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $60,314,000 | +1637.2% | 1,301,849 | +814.2% | 0.02% | +2200.0% |
| Q1 2019 | $3,472,000 | +37.5% | 142,401 | -19.7% | 0.00% | 0.0% |
| Q4 2018 | $2,526,000 | +12.9% | 177,310 | +20.4% | 0.00% | 0.0% |
| Q3 2018 | $2,238,000 | +31.0% | 147,246 | +44.6% | 0.00% | 0.0% |
| Q2 2018 | $1,709,000 | -66.6% | 101,858 | -67.5% | 0.00% | -50.0% |
| Q1 2018 | $5,117,000 | +316.7% | 313,545 | +227.0% | 0.00% | +100.0% |
| Q4 2017 | $1,228,000 | +6.7% | 95,873 | +2.5% | 0.00% | 0.0% |
| Q3 2017 | $1,151,000 | +19.2% | 93,561 | -18.9% | 0.00% | – |
| Q2 2017 | $966,000 | +189.2% | 115,405 | +209.3% | 0.00% | – |
| Q1 2017 | $334,000 | -77.3% | 37,315 | -77.7% | 0.00% | -100.0% |
| Q4 2016 | $1,472,000 | +654.9% | 167,519 | +480.0% | 0.00% | – |
| Q3 2016 | $195,000 | -32.5% | 28,884 | -64.4% | 0.00% | – |
| Q2 2016 | $289,000 | +60.6% | 81,075 | +32.8% | 0.00% | – |
| Q1 2016 | $180,000 | -85.9% | 61,046 | -79.8% | 0.00% | -100.0% |
| Q4 2015 | $1,277,000 | +289.3% | 302,515 | +320.6% | 0.00% | – |
| Q3 2015 | $328,000 | -26.0% | 71,927 | +17.2% | 0.00% | – |
| Q2 2015 | $443,000 | -75.6% | 61,371 | -75.1% | 0.00% | – |
| Q1 2015 | $1,816,000 | +530.6% | 246,524 | +304.8% | 0.00% | – |
| Q4 2014 | $288,000 | – | 60,895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |